Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mack

Showing results (141-150 of 214) with videos related to

Pageof 22
Sort By:
International Journal of Cardiology|September 3, 2013
Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) TrialVasim Farooq, Patrick W Serruys, Pascal Vranckx, et al.
JAMA Cardiology|August 4, 2020
One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart ValveBrian Whisenant, Samir R Kapadia, Mackram F Eleid, et al.
JACC. Cardiovascular Interventions|April 8, 2022
5-Year Follow-Up From the PARTNER 2 Aortic Valve-in-Valve Registry for Degenerated Aortic Surgical BioprosthesesRebecca T Hahn, John Webb, Philippe Pibarot, et al.
JACC. Cardiovascular Interventions|December 3, 2014
Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registryWilliam F Fearon, Susheel Kodali, Darshan Doshi, et al.
Circulation. Cardiovascular Interventions|September 8, 2016
Insights Into Timing, Risk Factors, and Outcomes of Stroke and Transient Ischemic Attack After Transcatheter Aortic Valve Replacement in the PARTNER Trial (Placement of Aortic Transcatheter Valves)Samir Kapadia, Shikhar Agarwal, D Craig Miller, et al.
European Heart Journal|October 3, 2014
Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomesSusheel Kodali, Philippe Pibarot, Pamela S Douglas, et al.
Journal of the American College of Cardiology|June 8, 2019
Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal DiseaseMolly Szerlip, Alan Zajarias, Sreekanth Vemalapalli, et al.
Journal of the American Heart Association|June 28, 2019
Stroke After Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention: Incidence, Pathogenesis, and OutcomesMario Gaudino, Dominick J Angiolillo, Antonino Di Franco, et al.
JAMA Cardiology|October 4, 2017
Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 ValvePhilippe Pibarot, Rebecca T Hahn, Neil J Weissman, et al.
JACC. Cardiovascular Interventions|October 30, 2023
1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study ResultsFiras Zahr, Howard K Song, Scott Chadderdon, et al.
Pageof 22

Showing results (141-150 of 214) with videos related to

Sort By:
Pageof 22
International Journal of Cardiology|September 3, 2013
Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) TrialVasim Farooq, Patrick W Serruys, Pascal Vranckx, et al.
JAMA Cardiology|August 4, 2020
One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart ValveBrian Whisenant, Samir R Kapadia, Mackram F Eleid, et al.
JACC. Cardiovascular Interventions|April 8, 2022
5-Year Follow-Up From the PARTNER 2 Aortic Valve-in-Valve Registry for Degenerated Aortic Surgical BioprosthesesRebecca T Hahn, John Webb, Philippe Pibarot, et al.
JACC. Cardiovascular Interventions|December 3, 2014
Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registryWilliam F Fearon, Susheel Kodali, Darshan Doshi, et al.
Circulation. Cardiovascular Interventions|September 8, 2016
Insights Into Timing, Risk Factors, and Outcomes of Stroke and Transient Ischemic Attack After Transcatheter Aortic Valve Replacement in the PARTNER Trial (Placement of Aortic Transcatheter Valves)Samir Kapadia, Shikhar Agarwal, D Craig Miller, et al.
European Heart Journal|October 3, 2014
Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomesSusheel Kodali, Philippe Pibarot, Pamela S Douglas, et al.
Journal of the American College of Cardiology|June 8, 2019
Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal DiseaseMolly Szerlip, Alan Zajarias, Sreekanth Vemalapalli, et al.
Journal of the American Heart Association|June 28, 2019
Stroke After Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention: Incidence, Pathogenesis, and OutcomesMario Gaudino, Dominick J Angiolillo, Antonino Di Franco, et al.
JAMA Cardiology|October 4, 2017
Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 ValvePhilippe Pibarot, Rebecca T Hahn, Neil J Weissman, et al.
JACC. Cardiovascular Interventions|October 30, 2023
1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study ResultsFiras Zahr, Howard K Song, Scott Chadderdon, et al.
Pageof 22